Sec. 4. Warning label
318 words·~1 min read·
/bill/119/s/1885/is/section-4A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
A covered platform provider shall— each time a user accesses the covered platform of the provider while physically located in the United States, clearly and conspicuously display a mental health warning label (referred to in this section as a covered label ) that complies with the requirements under this section, including the regulations promulgated under subsection (d); cause the covered label to disappear only if the user— exits the covered platform; or acknowledges the potential for harm and chooses to proceed to the covered platform despite the risk; and if a user acknowledges the potential for harm and chooses to proceed to the covered platform in accordance with paragraph (2)(B), redisplay such covered label after each hour of continuous use by such user.
A covered label shall— warn the user of potential negative mental health impacts of accessing the covered platform; and provide the user access to Federal resources to address the potential negative mental health impacts described in paragraph (1), including the 988 Suicide and Crisis Lifeline. A covered platform provider may not— include a covered label exclusively through a hyperlink or in the terms and conditions of the covered platform; include extraneous information in a covered label that obscures the visibility or prominence of the covered label; or allow a user to disable a covered label, except as provided in subsection (a).
Not later than 180 days after the date of enactment of this Act, the Commission, with the concurrence of the Secretary acting through the Surgeon General, shall promulgate regulations containing appropriate requirements for a covered label. Not later than 5 years after the date on which the Commission promulgates the regulations required by subsection (d), and not less frequently than once every 5 years thereafter, the Commission, with the concurrence of the Secretary acting through the Surgeon General, shall review and revise such regulations to address changes in technology, market conditions, and medical science.